The Link Between Colon Cancer and Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE)

Overview

Journal Am J Ophthalmol Case Rep

Specialty Ophthalmology

Date 2019 Aug 7

PMID 31384696

Citations 1

Authors

Brent Deibert

Letisha Ferris

Noel Sanchez

Paul Weishaar

Affiliations

Soon will be listed here.

Abstract

Purpose: Clarify the differences between Familial Adenomatous Polyposis (FAP)-associated Congenital Hypertrophy of the Retinal Epithelium (CHRPE) and benign variants with regards to lesion characteristics and associated risk.

Observations: An eighteen-year-old man with no past medical history was found to have multiple lesions in both eyes that were consistent with FAP-associated CHRPE. Although family history was negative for colon cancer, a colonoscopy was performed, and hundreds of polyps were found extending from the rectum to the distal colon with pathological findings of tubular adenoma. Genetic testing was consistent with a possible Adenomatous Polyposis Coli (APC) mutation.

Conclusions: FAP is an autosomal dominant syndrome that causes colorectal cancer by age thirty-five in ninety-five percent of cases. There has been no established relationship between the benign variants of CHRPE and FAP, and patients with benign variants have no increased risk of colon cancer. While the lack of distinction in nomenclature and similar lesion appearance often leads to misdiagnosis and overtreatment, there are distinct ocular exam features that can provide the correct diagnosis. The exam findings that distinguish FAP-associated CHRPE lesions are (1) bilateralism, (2) occurrence in multiple quadrants, (3) pisiform shape, and (4) irregular borders. Knowing these features can be of great aid, especially in the setting of suspected Familial Adenomatous Polyposis.

Citing Articles

Diagnostic implications of Gardner Syndrome, case report of a familial adenomatous polyposis (FAP) variant, for eye care professionals.

Babel A, Chin E, Almeida D Int J Surg Case Rep. 2024; 116:109379.

PMID: 38350372 PMC: 10943999. DOI: 10.1016/j.ijscr.2024.109379.

References

Neklason D, Stevens J, Boucher K, Kerber R, Matsunami N, Barlow J . American founder mutation for attenuated familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2007; 6(1):46-52. PMC: 2245898. DOI: 10.1016/j.cgh.2007.09.017. View

Brosens L, Wood L, Offerhaus G, Arnold C, Lam-Himlin D, Giardiello F . Pathology and Genetics of Syndromic Gastric Polyps. Int J Surg Pathol. 2016; 24(3):185-99. DOI: 10.1177/1066896915620013. View

Blair N, Trempe C . Hypertrophy of the retinal pigment epithelium associated with Gardner's syndrome. Am J Ophthalmol. 1980; 90(5):661-7. DOI: 10.1016/s0002-9394(14)75133-5. View

Sandoval J, Fernandez-Pineda I, Malkan A . Risk-reduction surgery in pediatric surgical oncology: A perspective. J Pediatr Surg. 2016; 51(4):675-87. DOI: 10.1016/j.jpedsurg.2016.01.004. View

Ghorbanoghli Z, Nieuwenhuis M, Houwing-Duistermaat J, Jagmohan-Changur S, Hes F, Tops C . Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers. Fam Cancer. 2016; 15(4):563-70. PMC: 5010832. DOI: 10.1007/s10689-016-9877-5. View

Arepalli S, Kaliki S, Shields J, Shields C . Growth of congenital hypertrophy of the retinal pigment epithelium over 22 years. J Pediatr Ophthalmol Strabismus. 2012; 49 Online:e73-5. DOI: 10.3928/01913913-20121211-04. View

Jarrar A, Milas M, Mitchell J, LaGuardia L, OMalley M, Berber E . Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg. 2010; 253(3):515-21. DOI: 10.1097/SLA.0b013e3181fcba8a. View

Shields C, Materin M, Walker C, Marr B, Shields J . Photoreceptor loss overlying congenital hypertrophy of the retinal pigment epithelium by optical coherence tomography. Ophthalmology. 2006; 113(4):661-5. DOI: 10.1016/j.ophtha.2005.10.057. View

Shields C, Manalac J, Das C, Saktanasate J, Shields J . Review of spectral domain-enhanced depth imaging optical coherence tomography of tumors of the retina and retinal pigment epithelium in children and adults. Indian J Ophthalmol. 2015; 63(2):128-32. PMC: 4399121. DOI: 10.4103/0301-4738.154384. View

10.

Aretz S, Uhlhaas S, Caspari R, Mangold E, Pagenstecher C, Propping P . Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet. 2003; 12(1):52-8. DOI: 10.1038/sj.ejhg.5201088. View

11.

Shields C, Mashayekhi A, Ho T, Cater J, Shields J . Solitary congenital hypertrophy of the retinal pigment epithelium: clinical features and frequency of enlargement in 330 patients. Ophthalmology. 2003; 110(10):1968-76. DOI: 10.1016/S0161-6420(03)00618-3. View

12.

Shields J, Eagle Jr R, Shields C, Brown G, Lally S . Malignant transformation of congenital hypertrophy of the retinal pigment epithelium. Ophthalmology. 2009; 116(11):2213-6. DOI: 10.1016/j.ophtha.2009.04.048. View

13.

Shields C, Pirondini C, Bianciotto C, Harmon S, Shields J . Autofluorescence of congenital hypertrophy of the retinal pigment epithelium. Retina. 2007; 27(8):1097-100. DOI: 10.1097/IAE.0b013e318133a174. View

14.

Shields J, Shields C, Shah P, Pastore D, Imperiale Jr S . Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner syndrome. Ophthalmology. 1992; 99(11):1709-13. DOI: 10.1016/s0161-6420(92)31736-1. View

15.

Herraiz M, Barbesino G, Faquin W, Chan-Smutko G, Patel D, Shannon K . Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol. 2007; 5(3):367-73. DOI: 10.1016/j.cgh.2006.10.019. View

16.

Ponti G, Tomasi A, Manfredini M, Pellacani G . Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies. Gene. 2016; 582(1):23-32. DOI: 10.1016/j.gene.2016.01.053. View

17.

Traboulsi E, Murphy S, De La Cruz Z, Maumenee I, Green W . A clinicopathologic study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardner's syndrome). Am J Ophthalmol. 1990; 110(5):550-61. DOI: 10.1016/s0002-9394(14)77880-8. View

18.

Church J, Burke C, McGannon E, Pastean O, Clark B . Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum. 2003; 46(9):1175-81. DOI: 10.1007/s10350-004-6710-2. View

19.

Syngal S, Brand R, Church J, Giardiello F, Hampel H, Burt R . ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015; 110(2):223-62. PMC: 4695986. DOI: 10.1038/ajg.2014.435. View